These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunopathology of bullous diseases. Jablonska S Ann Clin Res; 1970 Mar; 2(1):7-12. PubMed ID: 4912135 [No Abstract] [Full Text] [Related]
6. Autoimmunity in pemphigus. Chorzelski TP; von Weiss JF; Lever WF Pathol Eur; 1966; 1(1):268-72. PubMed ID: 4865669 [No Abstract] [Full Text] [Related]
7. [The immunofluorescent method as a diagnostic aid in bullous skin disease]. Feuerman E; Nir M; Joshua H; Gutglas H Harefuah; 1972 Jul; 83(1):10-3. PubMed ID: 4563871 [No Abstract] [Full Text] [Related]
8. [Pemphigus herpetiformis: a clinical variant of pemphigus vulgaris]. Bauer R; Orfanos CE Hautarzt; 1980 Oct; 31(10):540-4. PubMed ID: 7005184 [TBL] [Abstract][Full Text] [Related]
9. [Differential diagnosis of pemphigus vulgaris, bullous pemphigoid and dermatitis herpetiformis]. Lever WF Med Klin; 1967 Jul; 62(30):1173-6. PubMed ID: 4875201 [No Abstract] [Full Text] [Related]
10. [The value of the immunofluorescence test in the diagnosis of vesicular dermatoses]. Antonova TN; Kiseleva ML; Trofimova LIa Vestn Dermatol Venerol; 1972 Apr; 46(4):41-4. PubMed ID: 4559451 [No Abstract] [Full Text] [Related]
11. [The mechanism of autoimmune cutaneous diseases]. Jablonska S; Chorzelski T Ann Dermatol Syphiligr (Paris); 1971; 98(4):377-92. PubMed ID: 4945246 [No Abstract] [Full Text] [Related]
12. [Immunofluorescence study of skin fixation of Fab and Fc fragments of the serum of patients with Durhing-Brocq disease (bullous pemphigoid) and pemphigus]. Delpech B; Delpech-Stewart A; Lauret P; Stewart WM Ann Dermatol Syphiligr (Paris); 1971; 98(3):299-305. PubMed ID: 4942011 [No Abstract] [Full Text] [Related]
13. [Immunosuppressive agents and bullous diseases]. Beurey J; Weber M; Vadot J; Touret D Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):384-9. PubMed ID: 5510732 [No Abstract] [Full Text] [Related]
14. Linear IgA bullous dermatosis clinically simulating pemphigus vulgaris. Tanita Y; Masu S; Kato T; Tagami H Arch Dermatol; 1986 Mar; 122(3):246-8. PubMed ID: 3954389 [No Abstract] [Full Text] [Related]
15. [Value of immunofluorescence in severe bullous dermatitis]. Bureau B Sem Hop; 1972 Apr; 48(17):1209-21. PubMed ID: 4341283 [No Abstract] [Full Text] [Related]
16. [New aspects of immunofluorescent diagnostics in bullous skin diseases. II. Pemphigoid and Duhring's disease]. Chorzelski T; Maciejowska E; Jarzabek M Przegl Dermatol; 1971; 58(3):343-7. PubMed ID: 4944034 [No Abstract] [Full Text] [Related]
17. Endomysium and antigliadin antibodies in dermatitis herpetiformis and other bullous diseases. Economidou J; Avgerinou G; Tsiroyianni A; Stavropoulos P; Vareltzidis A; Katsambas A J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):184-5. PubMed ID: 9784051 [No Abstract] [Full Text] [Related]
18. Immunofluorescent test in bullous diseases of skin and mucous membranes. Michel B; Waisman M; Thomas CI; Levine M Ann Ophthalmol; 1974 Dec; 6(12):1311-6. PubMed ID: 4216284 [No Abstract] [Full Text] [Related]
19. [Autoantibodies in pemphigus and related diseases]. Panconesi E; Bigazzi PL Folia Allergol (Roma); 1970; 17(1):61-70. PubMed ID: 5445778 [No Abstract] [Full Text] [Related]
20. [Histological and clinicoimmunological studies in 40 cases of Duhring-Brocq disease]. Moulin G; Beyvin A; Valignat P Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):410-2. PubMed ID: 5150879 [No Abstract] [Full Text] [Related] [Next] [New Search]